Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction

Journal of the American College of Cardiology

Volumn 38, Issue 4, 2001, Pages 1207-1215

  Yu, Cheuk Man ^a,b   Tipoe, George L ^b   Wing Hon Lai, Kevin ^a   Lau, Chu Pak ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; COLLAGEN TYPE 1; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOSINOPRIL; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; VALSARTAN;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR EFFECT; CELL ACTIVATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; MORPHOMETRICS; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; COLLAGEN; DRUG COMBINATIONS; FIBROSIS; FOSINOPRIL; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TETRAZOLES; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; VALINE; VENTRICULAR REMODELING;

EID: 0034806667     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01518-2     Document Type: Article

References (34)

1. Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction
2. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the Survival And Ventricular Enlargement trial (the SAVE Investigators)
3. Angiotensin II-forming pathways in normal and failing human hearts
4. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat
5. Interstitial collagen is increased in the noninfarcted human myocardium after myocardial infarction
6. Long-term treatment with trandolapril opposes cardiac remodeling and prolongs survival after myocardial infarction in rats
7. Divergent effects of angiotensin-converting enzyme inhibition and angiotensin II-receptor antagonism on myocardial cellular proliferation and collagen deposition after myocardial infarction in rats
8. Colocalization of myocardial fibrosis and inflammatory cells in rats
9. Cardiac angiotensin-converting enzyme and myocardial fibrosis in the rat
10. Transforming growth factor beta-1 in acute myocardial infarction in rats
11. Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats
12. Experimental myocardial infarction in the rat: Qualitative and quantitative changes during pathologic evolution
13. Transforming growth factor beta 1 and renal injury following subtotal nephrectomy in the rat: Role of the renin-angiotensin system
14. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction
15. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections
16. The heterogeneity of mononuclear phagocytes in lymphoid organs: Distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3
17. Cytoskeletal characteristics of myofibroblasts in benign neoplastic and reactive fibroblastic lesions
18. Cytokine expression increases in nonmyocytes from rats with postinfarction heart failure
19. DNA synthesis in the noninfarcted cardiac interstitium after left coronary artery ligation in the rat: Effects of captopril
20. Antiproteinuric therapy while preventing the abnormal protein traffic in proximal tubule abrogates protein- and complement-dependent interstitial inflammation in experimental renal disease
21. Irbesartan, an angiotensin type 1 receptor inhibitor, regulates markers of inflammation in patients with premature atherosclerosis
22. Hypertrophic stimuli induce transforming growth factor-beta 1 expression in rat ventricular myocytes
23. Regulation of fibrillar collagen types I and III and basement membrane type IV collagen gene expression in pressure overloaded rat myocardium
24. Changes in cardiac angiotensin-converting enzyme after myocardial infarction and hypertrophy in rats
25. Identification of functional angiotensin II receptors on rat cardiac fibroblasts
26. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts: Critical role of the AT1 receptor subtype
27. Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction
28. Contractility and stiffness of noninfarcted myocardium after coronary ligation in rats: Effects of chronic angiotensin-converting enzyme inhibition
29. Enhanced reduction of myocardial infarct size by combined ACE inhibition and AT(1)-receptor antagonism
30. Enalapril improves arterial elastic properties in rats with myocardial infarction
31. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors
32. Cardioprotection induced by AT1R blockade after reperfused myocardial infarction: Association with regional increase in AT2R, IP3R and PKCepsilon proteins and cGMP
33. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure: Role of kinins and angiotensin II type 2 receptors
34. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases